Journal
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS
Volume 58, Issue 1, Pages 27-36Publisher
SPRINGER BASEL AG
DOI: 10.1007/s00005-009-0058-1
Keywords
Rheumatoid arthritis; Immunotherapy; Inflammatory cytokines; Autoreactive T cells; Regulatory T cells; Th17 cells
Categories
Funding
- Shanghai commission of Science and Technology (Shanghai Nature Science Foundation [07ZR14066, 08ZR1416100]
- NSFC [30972743]
- Shanghai Board of Health Foundation [2007126]
- Shanghai Institute of Immunology [08-A08]
- Shanghai Municipal Education Commission [09YZ104, J50207]
Ask authors/readers for more resources
Rheumatoid arthritis is a chronic disorder for which there is no known cure. Concentrating on specific elements of the abnormal immune response that characterizes the disease, scientists are reaching into biotechnology's bag of tricks to develop immunotherapeutic techniques. This paper will present some advances in the immunotherapy of rheumatoid arthritis targeting inflammatory cytokines and autoreactive T cells.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
